1. Smith PF , Maciennan K, Darliington CL: The properties of the Ginkgo biloba leaf: a review of the possible reiationship to platelet-activating factor (PAF). J Ethnopharmacol 1996; 50: 131-139. 2. Maitra L, Marcocci L, Droy-Lefaix MT, Packer L:Peroxyl radical scavenging activity of Ginkgo biloba extrac EGb 761. Biochem Pharmacol 1995; 49: 1649-1655. 3. Noda Y , et al , Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectraometer system. Biochem Mol Bio lint 1997; 42: 35-44. 4. Lo HM, et al . Effect of EGb 761, a ginkgo biloba extract, on early arrhyyhmia induced by coronary occlusion and reperfusion in dogs. J Formas Med Assac 1994; 93: 592-597 5. Haramaki N, et al. Aggarwal S, Kawabata T, Droy-Lefaix MT,Packer L: Effects of natural antioxidant ginkgo biloba extract (EGB 761) on myocardial ischemia-reperfusion injury. Free Radic Biol Med 1994; 16: 789-794. 6. Doly M, et al , Droy-Lefaix MT, Braquet P: Oxidative stress in diabetic retina. EXS 1992; 62:299-307 7. Montanini R, et al , Gaspari G: (Use of an extract of ginkgo biloba (Tebonin) in the therapy of cerebral vascular diseases). Minerva Cardioangiol 1969; 17: 1096-1102. 8. Meyer B: (Multicenter randomized double-blind drug vs. placebo study of the treatment of tinnitus with Ginkgo bilocba extract). Presse Med 1986; 15: 1562-1564 9. Haguenauer JP, et al . Cantenot F , Koskas H, Pierart H: (Treatment of equlllibrium disorders with Ginkgo biloba extract. A multicenter double-blind drug vs. placebo study). Pressr Med 1986; 15: 1569-1572. 10. Taillandier J, et al . Ammar A, Rabourdin JP , et al: (Treatment of cerebrai aging disorders with Gingkao Biloba extract. A longitudinal multicenter double-blind drug vs. placebo study). Presse Med 1986; 15: 1583-1587 11. Rai GS , et al . Shoviln C, Wesnes KA; A double-blind, placebo controlled study oh Gingkao biloba extract (tannakan) in elderly outpatients with mild to moderate memory impairment. Curr Med Res Opin 1991; 12: 350-355. 12. Garg RK, Nag D , Agrawal A: A double blind placebo controlled trial of gingkao biloba extract in acute cerebral ischaemia. J Assoc Physicians india 1995; 43: 760-763. 13. Mouren X, Caillard P , Schwartz F; Study of the antilschemic action of EGb 761 in the treatment of peripheral orterial occlusive disease by TcPo2 determination Angiology 1994; 45: 413-417. 14. Blume J , Kieser M, Holscher U: (Placebo-controlled double-blind study of the effectiveness of Ginkao biloba special extract EGb761 in trained patients witj intermittent claudication ). Vasa 1996; 25: 265-274. 15. Drabaek H, Petersen JR, Winberg N, Hansen KF, Mehisen J: (The effect of Ginkao biloaba extract in patients with intermitlent claudication). Ugeskr Laeger 1996; 158: 3928-3931 16. Palck JS, Lee JH: An experimental study of the effect of gingkao biloba extract on the human and rabbit corpus cavermosum tissue. J Ural 1996; 156: 1876-1880. 17. Le Bars PL, Katz MM, Berman N, ltil TM, Freedom AM. Schatzberg AF: A placebocontrolled, double-blind,randomizwd trial of an extract of Gingkao biloba for dementia. North American EGb Stidy Group. JAMA 1997; 278: 1327-1332. 18. Maurer K. ihl R, Dierks T, Frollch L: Clinical efficacy of Gingkao biloba special extract EGb 761 in dementia of the Aizheimer type (In process Citation). J Psychiatr Res 1997; 31: 645-655
1. Smith PF , Maciennan K, Darliington CL: The properties of the Ginkgo biloba leaf: a review of the possible reiationship to platelet-activating factor (PAF). J Ethnopharmacol 1996; 50: 131-139. 2. Maitra L, Marcocci L, Droy-Lefaix MT, Packer L:Peroxyl radical scavenging activity of Ginkgo biloba extrac EGb 761. Biochem Pharmacol 1995; 49: 1649-1655. 3. Noda Y , et al , Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectraometer system. Biochem Mol Bio lint 1997; 42: 35-44. 4. Lo HM, et al . Effect of EGb 761, a ginkgo biloba extract, on early arrhyyhmia induced by coronary occlusion and reperfusion in dogs. J Formas Med Assac 1994; 93: 592-597 5. Haramaki N, et al. Aggarwal S, Kawabata T, Droy-Lefaix MT,Packer L: Effects of natural antioxidant ginkgo biloba extract (EGB 761) on myocardial ischemia-reperfusion injury. Free Radic Biol Med 1994; 16: 789-794. 6. Doly M, et al , Droy-Lefaix MT, Braquet P: Oxidative stress in diabetic retina. EXS 1992; 62:299-307 7. Montanini R, et al , Gaspari G: (Use of an extract of ginkgo biloba (Tebonin) in the therapy of cerebral vascular diseases). Minerva Cardioangiol 1969; 17: 1096-1102. 8. Meyer B: (Multicenter randomized double-blind drug vs. placebo study of the treatment of tinnitus with Ginkgo bilocba extract). Presse Med 1986; 15: 1562-1564 9. Haguenauer JP, et al . Cantenot F , Koskas H, Pierart H: (Treatment of equlllibrium disorders with Ginkgo biloba extract. A multicenter double-blind drug vs. placebo study). Pressr Med 1986; 15: 1569-1572. 10. Taillandier J, et al . Ammar A, Rabourdin JP , et al: (Treatment of cerebrai aging disorders with Gingkao Biloba extract. A longitudinal multicenter double-blind drug vs. placebo study). Presse Med 1986; 15: 1583-1587 11. Rai GS , et al . Shoviln C, Wesnes KA; A double-blind, placebo controlled study oh Gingkao biloba extract (tannakan) in elderly outpatients with mild to moderate memory impairment. Curr Med Res Opin 1991; 12: 350-355. 12. Garg RK, Nag D , Agrawal A: A double blind placebo controlled trial of gingkao biloba extract in acute cerebral ischaemia. J Assoc Physicians india 1995; 43: 760-763. 13. Mouren X, Caillard P , Schwartz F; Study of the antilschemic action of EGb 761 in the treatment of peripheral orterial occlusive disease by TcPo2 determination Angiology 1994; 45: 413-417. 14. Blume J , Kieser M, Holscher U: (Placebo-controlled double-blind study of the effectiveness of Ginkao biloba special extract EGb761 in trained patients witj intermittent claudication ). Vasa 1996; 25: 265-274. 15. Drabaek H, Petersen JR, Winberg N, Hansen KF, Mehisen J: (The effect of Ginkao biloaba extract in patients with intermitlent claudication). Ugeskr Laeger 1996; 158: 3928-3931 16. Palck JS, Lee JH: An experimental study of the effect of gingkao biloba extract on the human and rabbit corpus cavermosum tissue. J Ural 1996; 156: 1876-1880. 17. Le Bars PL, Katz MM, Berman N, ltil TM, Freedom AM. Schatzberg AF: A placebocontrolled, double-blind,randomizwd trial of an extract of Gingkao biloba for dementia. North American EGb Stidy Group. JAMA 1997; 278: 1327-1332. 18. Maurer K. ihl R, Dierks T, Frollch L: Clinical efficacy of Gingkao biloba special extract EGb 761 in dementia of the Aizheimer type (In process Citation). J Psychiatr Res 1997; 31: 645-655